{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["DISCUSSION"], "sentence": "DISCUSSION", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["Many", "genetic", "lesions", "are", "known", "to", "influence", "gene", "expression", "of", "tumor", "suppressor", "genes", "."], "sentence": "Many genetic lesions are known to influence gene expression of tumor suppressor genes .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["Whereas", "mutations", "and", "deletions", "or", "insertions", "have", "permanent", "effects", ",", "reversible", "mechanisms", "are", "gene", "methylation", ",", "or", "expression", "and", "activation", "of", "transcription", "factors", ",", "respectively", "."], "sentence": "Whereas mutations and deletions or insertions have permanent effects , reversible mechanisms are gene methylation , or expression and activation of transcription factors , respectively .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S4", "tokens": ["We", "studied", "a", "putative", "cause", "for", "absent", "IRF-4", "expression", "in", "leukemia", "cells", "and", "first", "focused", "on", "genetic", "aberrations", "of", "the", "promoter", "."], "sentence": "We studied a putative cause for absent IRF-4 expression in leukemia cells and first focused on genetic aberrations of the promoter .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "absent", "start": 6, "end": 6}, "arguments": [{"entity_id": "T64", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T1", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T63", "text": "absent", "entity_type": "Negative_regulation", "start": 6, "end": 6}, {"id": "T64", "text": "expression", "entity_type": "Gene_expression", "start": 8, "end": 8}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S5", "tokens": ["We", "observed", "no", "genetic", "alterations", "in", "the", "IRF-4", "promoter", ",", "which", "can", "account", "for", "the", "lack", "of", "IRF-4", "expression", ":", "The", "detected", "base", "pair", "changes", "at", "position", "-1081", "(", "T", "--", ">", "C", "substitution", ")", ",", "at", "position", "-1068", "(", "A", "--", ">", "C", "substitution", ")", "and", "at", "position", "-116", "(", "A", "--", ">", "C", "substitution", ")", "are", "unlikely", "responsible", "for", "absent", "IRF-4", "-", "expression", "since", "the", "first", "two", "mutations", "were", "found", "both", "in", "IRF-4", "-", "positive", "and", "-", "negative", "cells", "whereas", "the", "latter", "change", "was", "not", "detected", "consistently", "in", "all", "IRF-4", "-", "negative", "or", "-", "positive", "cells", "and", "may", "thus", "be", "a", "polymorphism", "."], "sentence": "We observed no genetic alterations in the IRF-4 promoter , which can account for the lack of IRF-4 expression : The detected base pair changes at position -1081 ( T -- > C substitution ) , at position -1068 ( A -- > C substitution ) and at position -116 ( A -- > C substitution ) are unlikely responsible for absent IRF-4 - expression since the first two mutations were found both in IRF-4 - positive and - negative cells whereas the latter change was not detected consistently in all IRF-4 - negative or - positive cells and may thus be a polymorphism .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "lack", "start": 15, "end": 15}, "arguments": [{"entity_id": "T66", "text": "expression", "role": "Theme"}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 18, "end": 18}, "arguments": [{"entity_id": "T3", "text": "IRF-4", "role": "Theme"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "responsible", "start": 59, "end": 59}, "arguments": [{"entity_id": "T68", "text": "absent", "role": "Theme"}]}, {"id": "E6", "event_type": "Negative_regulation", "trigger": {"text": "absent", "start": 61, "end": 61}, "arguments": [{"entity_id": "T69", "text": "expression", "role": "Theme"}]}, {"id": "E7", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 64, "end": 64}, "arguments": [{"entity_id": "T4", "text": "IRF-4", "role": "Theme"}]}, {"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 76, "end": 76}, "arguments": [{"entity_id": "T5", "text": "IRF-4", "role": "Theme"}]}, {"id": "E9", "event_type": "Gene_expression", "trigger": {"text": "negative", "start": 79, "end": 79}, "arguments": [{"entity_id": "T5", "text": "IRF-4", "role": "Theme"}]}, {"id": "E10", "event_type": "Gene_expression", "trigger": {"text": "negative", "start": 93, "end": 93}, "arguments": [{"entity_id": "T6", "text": "IRF-4", "role": "Theme"}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 96, "end": 96}, "arguments": [{"entity_id": "T6", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T3", "text": "IRF-4", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T4", "text": "IRF-4", "entity_type": "Protein", "start": 62, "end": 62}, {"id": "T5", "text": "IRF-4", "entity_type": "Protein", "start": 74, "end": 74}, {"id": "T6", "text": "IRF-4", "entity_type": "Protein", "start": 91, "end": 91}, {"id": "T65", "text": "lack", "entity_type": "Negative_regulation", "start": 15, "end": 15}, {"id": "T66", "text": "expression", "entity_type": "Gene_expression", "start": 18, "end": 18}, {"id": "T67", "text": "responsible", "entity_type": "Positive_regulation", "start": 59, "end": 59}, {"id": "T68", "text": "absent", "entity_type": "Negative_regulation", "start": 61, "end": 61}, {"id": "T69", "text": "expression", "entity_type": "Gene_expression", "start": 64, "end": 64}, {"id": "T70", "text": "positive", "entity_type": "Gene_expression", "start": 76, "end": 76}, {"id": "T71", "text": "negative", "entity_type": "Gene_expression", "start": 79, "end": 79}, {"id": "T72", "text": "negative", "entity_type": "Gene_expression", "start": 93, "end": 93}, {"id": "T73", "text": "positive", "entity_type": "Gene_expression", "start": 96, "end": 96}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["All", "three", "substitutions", "did", "not", "change", "any", "known", "putative", "transcription", "factor", "binding", "sites", "(", "30", ",", "31", ")", "and", "also", "do", "not", "affect", "any", "restriction", "sites", "or", "primer", "binding", "sites", "of", "the", "used", "assays", "."], "sentence": "All three substitutions did not change any known putative transcription factor binding sites ( 30 , 31 ) and also do not affect any restriction sites or primer binding sites of the used assays .", "event_mentions": [], "entity_mentions": [{"id": "T74", "text": "change", "entity_type": "Regulation", "start": 5, "end": 5}, {"id": "T76", "text": "affect", "entity_type": "Regulation", "start": 22, "end": 22}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S7", "tokens": ["However", ",", "permanent", "genetic", "variations", "in", "the", "IRF-4", "coding", "sequence", ",", "such", "as", "deletions", "or", "mutations", "resulting", "in", "stop-codons", "have", "not", "been", "excluded", "by", "sequence", "analysis", "."], "sentence": "However , permanent genetic variations in the IRF-4 coding sequence , such as deletions or mutations resulting in stop-codons have not been excluded by sequence analysis .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S8", "tokens": ["Since", "IRF-4", "expression", "in", "cell", "lines", "and", "CML", "can", "be", "induced", "by", "demethylation", "and", "successful", "IFN-alpha", "therapy", "(", "3", ")", ",", "respectively", ",", "the", "existence", "of", "such", "genetic", "aberrations", "seems", "unlikely", "."], "sentence": "Since IRF-4 expression in cell lines and CML can be induced by demethylation and successful IFN-alpha therapy ( 3 ) , respectively , the existence of such genetic aberrations seems unlikely .", "event_mentions": [{"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 2, "end": 2}, "arguments": [{"entity_id": "T8", "text": "IRF-4", "role": "Theme"}]}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 10, "end": 10}, "arguments": [{"entity_id": "T79", "text": "expression", "role": "Theme"}, {"entity_id": "T9", "text": "IFN-alpha", "role": "Cause"}]}], "entity_mentions": [{"id": "T8", "text": "IRF-4", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T9", "text": "IFN-alpha", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T79", "text": "expression", "entity_type": "Gene_expression", "start": 2, "end": 2}, {"id": "T80", "text": "induced", "entity_type": "Positive_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S9", "tokens": ["We", "then", "investigated", "whether", "the", "previously", "described", "down-regulation", "of", "IRF-4", "expression", "in", "human", "myeloid", "leukemias", "was", "due", "to", "a", "differential", "hypermethylation", "of", "the", "promoter", ",", "since", "the", "presented", "re-expression", "due", "to", "AzadC-treatment", "might", "also", "be", "a", "result", "of", "activation", "of", "positive", "transcriptional", "regulators", "of", "IRF-4", "."], "sentence": "We then investigated whether the previously described down-regulation of IRF-4 expression in human myeloid leukemias was due to a differential hypermethylation of the promoter , since the presented re-expression due to AzadC-treatment might also be a result of activation of positive transcriptional regulators of IRF-4 .", "event_mentions": [{"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "down-regulation", "start": 7, "end": 7}, "arguments": [{"entity_id": "T82", "text": "expression", "role": "Theme"}]}, {"id": "E18", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 10, "end": 10}, "arguments": [{"entity_id": "T10", "text": "IRF-4", "role": "Theme"}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "due", "start": 16, "end": 16}, "arguments": [{"entity_id": "T81", "text": "down-regulation", "role": "Theme"}]}, {"id": "E20", "event_type": "Gene_expression", "trigger": {"text": "re-expression", "start": 28, "end": 28}, "arguments": [{"entity_id": "T10", "text": "IRF-4", "role": "Theme"}]}, {"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "result", "start": 36, "end": 36}, "arguments": [{"entity_id": "T84", "text": "re-expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "IRF-4", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T11", "text": "IRF-4", "entity_type": "Protein", "start": 44, "end": 44}, {"id": "T81", "text": "down-regulation", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T82", "text": "expression", "entity_type": "Gene_expression", "start": 10, "end": 10}, {"id": "T83", "text": "due", "entity_type": "Positive_regulation", "start": 16, "end": 16}, {"id": "T84", "text": "re-expression", "entity_type": "Gene_expression", "start": 28, "end": 28}, {"id": "T85", "text": "result", "entity_type": "Positive_regulation", "start": 36, "end": 36}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S10", "tokens": ["Methylation", "of", "CpG", "sites", "is", "a", "common", "mechanism", "of", "silencing", "genes", "in", "leukemia", "and", "has", "also", "been", "shown", "for", "another", "IRF", ",", "IRF-7", "(", "35", ")", "and", "for", "PU.1", "(", "36", ")", ",", "an", "interacting", "partner", "of", "IRF-4", "."], "sentence": "Methylation of CpG sites is a common mechanism of silencing genes in leukemia and has also been shown for another IRF , IRF-7 ( 35 ) and for PU.1 ( 36 ) , an interacting partner of IRF-4 .", "event_mentions": [{"id": "E22", "event_type": "Binding", "trigger": {"text": "interacting", "start": 34, "end": 34}, "arguments": [{"entity_id": "T13", "text": "PU.1", "role": "Theme"}, {"entity_id": "T14", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T12", "text": "IRF-7", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T13", "text": "PU.1", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T14", "text": "IRF-4", "entity_type": "Protein", "start": 37, "end": 37}, {"id": "T86", "text": "interacting", "entity_type": "Binding", "start": 34, "end": 34}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S11", "tokens": ["To", "elucidate", "the", "relevance", "of", "this", "mechanism", "for", "the", "regulation", "of", "IRF-4", "expression", ",", "various", "leukemic", "cells", "were", "treated", "with", "demethylating", "agents", "and", "promoters", "were", "sequenced", "after", "bisulfite", "treatment", "."], "sentence": "To elucidate the relevance of this mechanism for the regulation of IRF-4 expression , various leukemic cells were treated with demethylating agents and promoters were sequenced after bisulfite treatment .", "event_mentions": [{"id": "E23", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 9, "end": 9}, "arguments": [{"entity_id": "T88", "text": "expression", "role": "Theme"}]}, {"id": "E24", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 12, "end": 12}, "arguments": [{"entity_id": "T15", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T15", "text": "IRF-4", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T87", "text": "regulation", "entity_type": "Regulation", "start": 9, "end": 9}, {"id": "T88", "text": "expression", "entity_type": "Gene_expression", "start": 12, "end": 12}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S12", "tokens": ["We", "found", "that", "IRF-4", "expression", "could", "indeed", "be", "connected", "to", "the", "methylation", "status", "of", "distinct", "CpG", "motifs", "in", "the", "IRF-4", "promoter", "."], "sentence": "We found that IRF-4 expression could indeed be connected to the methylation status of distinct CpG motifs in the IRF-4 promoter .", "event_mentions": [{"id": "E25", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 4, "end": 4}, "arguments": [{"entity_id": "T16", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T16", "text": "IRF-4", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T17", "text": "IRF-4", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T89", "text": "expression", "entity_type": "Gene_expression", "start": 4, "end": 4}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S13", "tokens": ["In", "Figure", "4A", ",", "those", "CpG", "sites", "are", "shown", "(", "bottom", "line", ")", ",", "whose", "hypermethylation", "may", "account", "for", "the", "absence", "of", "IRF-4", "expression", "in", "the", "respective", "cells", "."], "sentence": "In Figure 4A , those CpG sites are shown ( bottom line ) , whose hypermethylation may account for the absence of IRF-4 expression in the respective cells .", "event_mentions": [{"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "account", "start": 17, "end": 17}, "arguments": [{"entity_id": "T91", "text": "absence", "role": "Theme"}]}, {"id": "E27", "event_type": "Negative_regulation", "trigger": {"text": "absence", "start": 20, "end": 20}, "arguments": [{"entity_id": "T92", "text": "expression", "role": "Theme"}]}, {"id": "E28", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 23, "end": 23}, "arguments": [{"entity_id": "T18", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T18", "text": "IRF-4", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T90", "text": "account", "entity_type": "Positive_regulation", "start": 17, "end": 17}, {"id": "T91", "text": "absence", "entity_type": "Negative_regulation", "start": 20, "end": 20}, {"id": "T92", "text": "expression", "entity_type": "Gene_expression", "start": 23, "end": 23}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["One", "of", "them", "(", "#", "54", ")", "is", "adjacent", "to", "an", "identified", "regulatory", "element", "(", "NFkappaB-site", ")", ",", "indicating", "a", "possible", "involvement", "of", "this", "site", "."], "sentence": "One of them ( # 54 ) is adjacent to an identified regulatory element ( NFkappaB-site ) , indicating a possible involvement of this site .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S15", "tokens": ["At", "two", "further", "CpG", "sites", "(", "#", "48", ",", "45", ")", "the", "methylation", "status", "in", "IRF-4", "-", "positive", "was", "lower", "than", "that", "of", "IRF-4", "-", "negative", "cells", "."], "sentence": "At two further CpG sites ( # 48 , 45 ) the methylation status in IRF-4 - positive was lower than that of IRF-4 - negative cells .", "event_mentions": [{"id": "E29", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 17, "end": 17}, "arguments": [{"entity_id": "T19", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T19", "text": "IRF-4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T20", "text": "IRF-4", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T93", "text": "positive", "entity_type": "Gene_expression", "start": 17, "end": 17}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S16", "tokens": ["These", "CpG", "sites", "are", "located", "in", "an", "NFkappaB", "and", "an", "SP1", "element", "(", "31", ")", "and", "thus", "may", "also", "play", "a", "role", "in", "regulation", "of", "IRF-4", "expression", "."], "sentence": "These CpG sites are located in an NFkappaB and an SP1 element ( 31 ) and thus may also play a role in regulation of IRF-4 expression .", "event_mentions": [{"id": "E30", "event_type": "Regulation", "trigger": {"text": "role", "start": 21, "end": 21}, "arguments": [{"entity_id": "T95", "text": "regulation", "role": "Theme"}]}, {"id": "E31", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 23, "end": 23}, "arguments": [{"entity_id": "T96", "text": "expression", "role": "Theme"}]}, {"id": "E32", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 26, "end": 26}, "arguments": [{"entity_id": "T21", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T21", "text": "IRF-4", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T94", "text": "role", "entity_type": "Regulation", "start": 21, "end": 21}, {"id": "T95", "text": "regulation", "entity_type": "Regulation", "start": 23, "end": 23}, {"id": "T96", "text": "expression", "entity_type": "Gene_expression", "start": 26, "end": 26}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S17", "tokens": ["It", "has", "been", "shown", "that", "NFkappaB", "elements", "play", "an", "important", "role", "in", "IRF-4", "induction", "as", "IRF-4", "expression", "depends", "on", "binding", "of", "the", "transactivator", "c-Rel", "to", "these", "elements", "in", "the", "IRF-4", "promoter", "(", "31", ",", "37", ")", "."], "sentence": "It has been shown that NFkappaB elements play an important role in IRF-4 induction as IRF-4 expression depends on binding of the transactivator c-Rel to these elements in the IRF-4 promoter ( 31 , 37 ) .", "event_mentions": [{"id": "E33", "event_type": "Regulation", "trigger": {"text": "important role", "start": 9, "end": 10}, "arguments": [{"entity_id": "T99", "text": "induction", "role": "Theme"}, {"entity_id": "T25", "text": "IRF-4", "role": "Cause"}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 13, "end": 13}, "arguments": [{"entity_id": "T22", "text": "IRF-4", "role": "Theme"}]}, {"id": "E35", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 16, "end": 16}, "arguments": [{"entity_id": "T23", "text": "IRF-4", "role": "Theme"}]}, {"id": "E36", "event_type": "Positive_regulation", "trigger": {"text": "depends", "start": 17, "end": 17}, "arguments": [{"entity_id": "T100", "text": "expression", "role": "Theme"}, {"entity_id": "T102", "text": "binding", "role": "Cause"}]}, {"id": "E37", "event_type": "Binding", "trigger": {"text": "binding", "start": 19, "end": 19}, "arguments": [{"entity_id": "T24", "text": "c-Rel", "role": "Theme"}, {"entity_id": "T25", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T22", "text": "IRF-4", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T23", "text": "IRF-4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T24", "text": "c-Rel", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T25", "text": "IRF-4", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T98", "text": "important role", "entity_type": "Regulation", "start": 9, "end": 10}, {"id": "T99", "text": "induction", "entity_type": "Positive_regulation", "start": 13, "end": 13}, {"id": "T100", "text": "expression", "entity_type": "Gene_expression", "start": 16, "end": 16}, {"id": "T101", "text": "depends", "entity_type": "Positive_regulation", "start": 17, "end": 17}, {"id": "T102", "text": "binding", "entity_type": "Binding", "start": 19, "end": 19}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S18", "tokens": ["Furthermore", ",", "methylation", "of", "the", "central", "CpG", "in", "the", "NFkappaB", "element", "inhibits", "binding", "of", "the", "NFkappaB", "protein", "complexes", "(", "38", ")", ",", "promoting", "the", "significance", "of", "the", "observed", "methylation", "differences", "in", "IRF-4", "-", "positive", "and", "-", "negative", "cells", "."], "sentence": "Furthermore , methylation of the central CpG in the NFkappaB element inhibits binding of the NFkappaB protein complexes ( 38 ) , promoting the significance of the observed methylation differences in IRF-4 - positive and - negative cells .", "event_mentions": [{"id": "E40", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 33, "end": 33}, "arguments": [{"entity_id": "T26", "text": "IRF-4", "role": "Theme"}]}, {"id": "E41", "event_type": "Gene_expression", "trigger": {"text": "negative", "start": 36, "end": 36}, "arguments": [{"entity_id": "T26", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T26", "text": "IRF-4", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T105", "text": "inhibits", "entity_type": "Negative_regulation", "start": 11, "end": 11}, {"id": "T106", "text": "binding", "entity_type": "Binding", "start": 12, "end": 12}, {"id": "T107", "text": "positive", "entity_type": "Gene_expression", "start": 33, "end": 33}, {"id": "T108", "text": "negative", "entity_type": "Gene_expression", "start": 36, "end": 36}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S19", "tokens": ["Via", "in", "vitro", "methylation", "and", "reporter", "gene", "assays", "we", "could", "clearly", "appoint", "the", "silencing", "of", "the", "IRF-4", "promoter", "to", "a", "methylation", "effect", ",", "which", "may", "thus", "be", "the", "mechanism", "of", "IRF-4", "deregulation", "in", "vivo", "."], "sentence": "Via in vitro methylation and reporter gene assays we could clearly appoint the silencing of the IRF-4 promoter to a methylation effect , which may thus be the mechanism of IRF-4 deregulation in vivo .", "event_mentions": [{"id": "E42", "event_type": "Negative_regulation", "trigger": {"text": "silencing", "start": 13, "end": 13}, "arguments": [{"entity_id": "T27", "text": "IRF-4", "role": "Theme"}]}, {"id": "E43", "event_type": "Regulation", "trigger": {"text": "deregulation", "start": 31, "end": 31}, "arguments": [{"entity_id": "T28", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T27", "text": "IRF-4", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T28", "text": "IRF-4", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T109", "text": "silencing", "entity_type": "Negative_regulation", "start": 13, "end": 13}, {"id": "T111", "text": "deregulation", "entity_type": "Regulation", "start": 31, "end": 31}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["One", "possible", "cause", "for", "the", "aberrant", "methylation", "in", "tumorigenesis", "is", "an", "increased", "level", "of", "DNMTs", "during", "the", "pathogenetic", "process", "."], "sentence": "One possible cause for the aberrant methylation in tumorigenesis is an increased level of DNMTs during the pathogenetic process .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S21", "tokens": ["In", "colon", ",", "lung", "and", "hematologic", "malignancies", ",", "overexpression", "of", "DNMT1", ",", "a", "maintenance", "DNMT", ",", "has", "been", "detected", "(", "39-41", ")", "."], "sentence": "In colon , lung and hematologic malignancies , overexpression of DNMT1 , a maintenance DNMT , has been detected ( 39-41 ) .", "event_mentions": [{"id": "E44", "event_type": "Positive_regulation", "trigger": {"text": "overexpression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T29", "text": "DNMT1", "role": "Theme"}]}], "entity_mentions": [{"id": "T29", "text": "DNMT1", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T112", "text": "overexpression", "entity_type": "Positive_regulation", "start": 8, "end": 8}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["Furthermore", ",", "it", "has", "been", "shown", "that", "CML", "cells", "in", "the", "acute", "phase", "exhibited", "elevated", "levels", "of", "the", "three", "known", "DNMTs", ",", "while", "CML", "cells", "in", "chronic", "phase", "expressed", "normal", "levels", "of", "DNMTs", "if", "compared", "with", "normal", "bone", "marrow", "cells", "(", "25", ")", "."], "sentence": "Furthermore , it has been shown that CML cells in the acute phase exhibited elevated levels of the three known DNMTs , while CML cells in chronic phase expressed normal levels of DNMTs if compared with normal bone marrow cells ( 25 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S23", "tokens": ["Interestingly", ",", "a", "positive", "correlation", "between", "DNMT1", "expression", "levels", "and", "hypermethylation", "of", "p15INK4b", "has", "been", "detected", "in", "AML", "(", "25", ")", "."], "sentence": "Interestingly , a positive correlation between DNMT1 expression levels and hypermethylation of p15INK4b has been detected in AML ( 25 ) .", "event_mentions": [{"id": "E45", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 7, "end": 7}, "arguments": [{"entity_id": "T30", "text": "DNMT1", "role": "Theme"}]}], "entity_mentions": [{"id": "T30", "text": "DNMT1", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T31", "text": "p15INK4b", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T113", "text": "expression", "entity_type": "Gene_expression", "start": 7, "end": 7}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S24", "tokens": ["In", "this", "work", ",", "we", "did", "not", "detect", "significant", "mRNA", "expression", "differences", "of", "selected", "DNMT", "or", "MBP", ",", "making", "it", "an", "unlikely", "cause", "for", "the", "observed", "methylation", "and", "thus", "IRF-4", "expression", "differences", "in", "leukemia", "cells", "."], "sentence": "In this work , we did not detect significant mRNA expression differences of selected DNMT or MBP , making it an unlikely cause for the observed methylation and thus IRF-4 expression differences in leukemia cells .", "event_mentions": [{"id": "E46", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 30, "end": 30}, "arguments": [{"entity_id": "T32", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T32", "text": "IRF-4", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T114", "text": "expression", "entity_type": "Gene_expression", "start": 30, "end": 30}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S25", "tokens": ["The", "finding", "that", "IRF-4", "expression", "is", "silenced", "by", "promoter", "hypermethylation", "might", "represent", "a", "mechanism", "that", "accounts", "for", "the", "previously", "observed", "loss", "of", "IRF-4", "expression", "in", "CML", "."], "sentence": "The finding that IRF-4 expression is silenced by promoter hypermethylation might represent a mechanism that accounts for the previously observed loss of IRF-4 expression in CML .", "event_mentions": [{"id": "E47", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 4, "end": 4}, "arguments": [{"entity_id": "T33", "text": "IRF-4", "role": "Theme"}]}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "loss", "start": 20, "end": 20}, "arguments": [{"entity_id": "T117", "text": "expression", "role": "Theme"}]}, {"id": "E49", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 23, "end": 23}, "arguments": [{"entity_id": "T34", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T33", "text": "IRF-4", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T34", "text": "IRF-4", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T115", "text": "expression", "entity_type": "Gene_expression", "start": 4, "end": 4}, {"id": "T116", "text": "loss", "entity_type": "Negative_regulation", "start": 20, "end": 20}, {"id": "T117", "text": "expression", "entity_type": "Gene_expression", "start": 23, "end": 23}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["Indeed", ",", "several", "clinical", "trials", "with", "leukemia", "patients", "and", "patients", "with", "myelodysplastic", "syndromes", "demonstrated", "the", "potential", "clinical", "benefit", "of", "a", "treatment", "with", "demethylating", "agents", "(", "42-45", ")", "."], "sentence": "Indeed , several clinical trials with leukemia patients and patients with myelodysplastic syndromes demonstrated the potential clinical benefit of a treatment with demethylating agents ( 42-45 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S27", "tokens": ["The", "expression", "of", "another", "IRF", ",", "IFN", "consensus", "sequence", "binding", "protein", "(", "ICSBP", "/", "IRF-8", ")", ",", "is", "impaired", "in", "myeloid", "leukemias", "especially", "CML", "(", "27", ",", "46", ",", "47", ")", "."], "sentence": "The expression of another IRF , IFN consensus sequence binding protein ( ICSBP / IRF-8 ) , is impaired in myeloid leukemias especially CML ( 27 , 46 , 47 ) .", "event_mentions": [{"id": "E50", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 1, "end": 1}, "arguments": [{"entity_id": "T35", "text": "IFN consensus sequence binding protein", "role": "Theme"}]}, {"id": "E51", "event_type": "Negative_regulation", "trigger": {"text": "impaired", "start": 18, "end": 18}, "arguments": [{"entity_id": "T118", "text": "expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T35", "text": "IFN consensus sequence binding protein", "entity_type": "Protein", "start": 6, "end": 10}, {"id": "T36", "text": "ICSBP", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T37", "text": "IRF-8", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T118", "text": "expression", "entity_type": "Gene_expression", "start": 1, "end": 1}, {"id": "T119", "text": "impaired", "entity_type": "Negative_regulation", "start": 18, "end": 18}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S28", "tokens": ["But", "in", "contrast", "to", "IRF-4", ",", "the", "loss", "of", "this", "IRF", "could", "not", "be", "reverted", "in", "ICSBP", "-", "negative", "cell", "lines", "(", "EM-2", ",", "CML-T1", ",", "K-562", "and", "LAMA-84", ")", "by", "treatment", "with", "AzadC", "(", "Figure", "6", ")", "and", "AzadC", "has", "no", "effect", "on", "ICSBP", "levels", "in", "ICSBP", "-", "positive", "U-937", "cells", "(", "Figure", "6", ")", "."], "sentence": "But in contrast to IRF-4 , the loss of this IRF could not be reverted in ICSBP - negative cell lines ( EM-2 , CML-T1 , K-562 and LAMA-84 ) by treatment with AzadC ( Figure 6 ) and AzadC has no effect on ICSBP levels in ICSBP - positive U-937 cells ( Figure 6 ) .", "event_mentions": [{"id": "E54", "event_type": "Gene_expression", "trigger": {"text": "negative", "start": 18, "end": 18}, "arguments": [{"entity_id": "T39", "text": "ICSBP", "role": "Theme"}]}, {"id": "E55", "event_type": "Regulation", "trigger": {"text": "effect", "start": 42, "end": 42}, "arguments": [{"entity_id": "T124", "text": "levels", "role": "Theme"}]}, {"id": "E56", "event_type": "Gene_expression", "trigger": {"text": "levels", "start": 45, "end": 45}, "arguments": [{"entity_id": "T40", "text": "ICSBP", "role": "Theme"}]}, {"id": "E57", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 49, "end": 49}, "arguments": [{"entity_id": "T41", "text": "ICSBP", "role": "Theme"}]}], "entity_mentions": [{"id": "T38", "text": "IRF-4", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T39", "text": "ICSBP", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T40", "text": "ICSBP", "entity_type": "Protein", "start": 44, "end": 44}, {"id": "T41", "text": "ICSBP", "entity_type": "Protein", "start": 47, "end": 47}, {"id": "T120", "text": "loss", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T121", "text": "reverted", "entity_type": "Negative_regulation", "start": 14, "end": 14}, {"id": "T122", "text": "negative", "entity_type": "Gene_expression", "start": 18, "end": 18}, {"id": "T123", "text": "effect", "entity_type": "Regulation", "start": 42, "end": 42}, {"id": "T124", "text": "levels", "entity_type": "Gene_expression", "start": 45, "end": 45}, {"id": "T125", "text": "positive", "entity_type": "Gene_expression", "start": 49, "end": 49}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "", "tokens": ["These", "data", "suggest", "a", "distinct", "regulatory", "mechanism", "for", "these", "two", "IRFs", "."], "sentence": "These data suggest a distinct regulatory mechanism for these two IRFs .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S30", "tokens": ["IRF-4", ",", "similar", "to", "many", "other", "classical", "tumor", "suppressor", "genes", "p15INK4b", ",", "p16INK4a", "or", "p53", ",", "may", "thus", "be", "a", "subject", "of", "alterations", "in", "the", "promoter", "methylation", "status", "leading", "to", "expression", "changes", ",", "which", "might", "contribute", "to", "the", "initiation", "and", "/", "or", "progression", "of", "cancer", "."], "sentence": "IRF-4 , similar to many other classical tumor suppressor genes p15INK4b , p16INK4a or p53 , may thus be a subject of alterations in the promoter methylation status leading to expression changes , which might contribute to the initiation and / or progression of cancer .", "event_mentions": [{"id": "E58", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 30, "end": 30}, "arguments": [{"entity_id": "T42", "text": "IRF-4", "role": "Theme"}]}, {"id": "E59", "event_type": "Regulation", "trigger": {"text": "changes", "start": 31, "end": 31}, "arguments": [{"entity_id": "T126", "text": "expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T42", "text": "IRF-4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T43", "text": "p15INK4b", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T44", "text": "p16INK4a", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T45", "text": "p53", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T126", "text": "expression", "entity_type": "Gene_expression", "start": 30, "end": 30}, {"id": "T127", "text": "changes", "entity_type": "Regulation", "start": 31, "end": 31}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S31", "tokens": ["Still", ",", "the", "obvious", "functional", "diversity", "of", "IRF-4", "remains", "remarkable", "and", "can", "not", "be", "fully", "explained", "by", "the", "IRF-4", "promoter", "methylation", "status", "."], "sentence": "Still , the obvious functional diversity of IRF-4 remains remarkable and can not be fully explained by the IRF-4 promoter methylation status .", "event_mentions": [], "entity_mentions": [{"id": "T46", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T47", "text": "IRF-4", "entity_type": "Protein", "start": 18, "end": 18}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S32", "tokens": ["For", "example", ",", "IRF-4", "is", "primarily", "known", "for", "its", "oncogenic", "features", "."], "sentence": "For example , IRF-4 is primarily known for its oncogenic features .", "event_mentions": [], "entity_mentions": [{"id": "T48", "text": "IRF-4", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S33", "tokens": ["In", "multiple", "myeloma", "(", "MM", ")", "a", "translocation", "on", "chromosome", "14q", "was", "reported", "to", "lead", "to", "a", "fusion", "gene", "of", "immunoglobulin", "heavy-chain", "(", "IgH", ")", "and", "IRF-4", "resulting", "in", "a", "subsequent", "overexpression", "of", "IRF-4", "(", "48", ",", "49", ")", "."], "sentence": "In multiple myeloma ( MM ) a translocation on chromosome 14q was reported to lead to a fusion gene of immunoglobulin heavy-chain ( IgH ) and IRF-4 resulting in a subsequent overexpression of IRF-4 ( 48 , 49 ) .", "event_mentions": [{"id": "E60", "event_type": "Positive_regulation", "trigger": {"text": "resulting", "start": 27, "end": 27}, "arguments": [{"entity_id": "T129", "text": "overexpression", "role": "Theme"}]}, {"id": "E61", "event_type": "Positive_regulation", "trigger": {"text": "overexpression", "start": 31, "end": 31}, "arguments": [{"entity_id": "T52", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T49", "text": "immunoglobulin heavy-chain", "entity_type": "Protein", "start": 20, "end": 21}, {"id": "T50", "text": "IgH", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T51", "text": "IRF-4", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T52", "text": "IRF-4", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T128", "text": "resulting", "entity_type": "Positive_regulation", "start": 27, "end": 27}, {"id": "T129", "text": "overexpression", "entity_type": "Positive_regulation", "start": 31, "end": 31}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S34", "tokens": ["In", "addition", ",", "abundant", "IRF-4", "expression", "was", "found", "to", "be", "a", "marker", "for", "various", "subsets", "of", "lymphomas", ",", "such", "as", "diffuse", "large", "B-cell", "lymphomas", ",", "primary", "effusion", "lymphoma", ",", "and", "marginal", "zone", "lymphoma", ",", "and", "adult", "T-cell", "leukemia", "(", "11", ",", "31", ",", "50-52", ")", "."], "sentence": "In addition , abundant IRF-4 expression was found to be a marker for various subsets of lymphomas , such as diffuse large B-cell lymphomas , primary effusion lymphoma , and marginal zone lymphoma , and adult T-cell leukemia ( 11 , 31 , 50-52 ) .", "event_mentions": [{"id": "E62", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T53", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T53", "text": "IRF-4", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T130", "text": "expression", "entity_type": "Gene_expression", "start": 5, "end": 5}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S35", "tokens": ["This", "draws", "a", "more", "complex", "picture", "of", "the", "role", "of", "IRF-4", "."], "sentence": "This draws a more complex picture of the role of IRF-4 .", "event_mentions": [], "entity_mentions": [{"id": "T54", "text": "IRF-4", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S36", "tokens": ["Down-regulation", "of", "IRF-4", "may", "promote", "leukemogenesis", "in", "myeloid", "cell", "context", "(", "3", ")", ",", "which", "was", "recently", "confirmed", "in", "IRF-4", "-", "/", "-", "ICSBP", "-", "/", "-", "double", "knock-out", "mice", "(", "53", ")", ",", "while", "IRF-4", "up-regulation", "may", "induce", "a", "growth", "advantage", "in", "lymphomas", "or", "MM", "(", "48", ")", "."], "sentence": "Down-regulation of IRF-4 may promote leukemogenesis in myeloid cell context ( 3 ) , which was recently confirmed in IRF-4 - / - ICSBP - / - double knock-out mice ( 53 ) , while IRF-4 up-regulation may induce a growth advantage in lymphomas or MM ( 48 ) .", "event_mentions": [{"id": "E63", "event_type": "Negative_regulation", "trigger": {"text": "Down-regulation", "start": 0, "end": 0}, "arguments": [{"entity_id": "T55", "text": "IRF-4", "role": "Theme"}]}, {"id": "E64", "event_type": "Gene_expression", "trigger": {"text": "knock-out", "start": 28, "end": 28}, "arguments": [{"entity_id": "T56", "text": "IRF-4", "role": "Theme"}]}, {"id": "E65", "event_type": "Gene_expression", "trigger": {"text": "knock-out", "start": 28, "end": 28}, "arguments": [{"entity_id": "T57", "text": "ICSBP", "role": "Theme"}]}, {"id": "E66", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 36, "end": 36}, "arguments": [{"entity_id": "T58", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T55", "text": "IRF-4", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T56", "text": "IRF-4", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T57", "text": "ICSBP", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T58", "text": "IRF-4", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T131", "text": "Down-regulation", "entity_type": "Negative_regulation", "start": 0, "end": 0}, {"id": "T132", "text": "knock-out", "entity_type": "Gene_expression", "start": 28, "end": 28}, {"id": "T133", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 36, "end": 36}]}
{"doc_id": "PMC-1310901-15-DISCUSSION.txt", "sent_id": "S37", "tokens": ["Taken", "together", ",", "our", "data", "suggest", "that", "IRF-4", "promoter", "methylation", "regulates", "IRF-4", "expression", ",", "and", "that", "aberrant", "expression", "of", "IRF-4", "in", "certain", "types", "of", "leukemia", "may", "be", "a", "consequence", "of", "IRF-4", "promoter", "hypermethylation", "."], "sentence": "Taken together , our data suggest that IRF-4 promoter methylation regulates IRF-4 expression , and that aberrant expression of IRF-4 in certain types of leukemia may be a consequence of IRF-4 promoter hypermethylation .", "event_mentions": [{"id": "E67", "event_type": "Regulation", "trigger": {"text": "regulates", "start": 10, "end": 10}, "arguments": [{"entity_id": "T135", "text": "expression", "role": "Theme"}]}, {"id": "E68", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 12, "end": 12}, "arguments": [{"entity_id": "T60", "text": "IRF-4", "role": "Theme"}]}, {"id": "E69", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 17, "end": 17}, "arguments": [{"entity_id": "T61", "text": "IRF-4", "role": "Theme"}]}, {"id": "E70", "event_type": "Positive_regulation", "trigger": {"text": "consequence", "start": 28, "end": 28}, "arguments": [{"entity_id": "T136", "text": "expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T59", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T60", "text": "IRF-4", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T61", "text": "IRF-4", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T62", "text": "IRF-4", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T134", "text": "regulates", "entity_type": "Regulation", "start": 10, "end": 10}, {"id": "T135", "text": "expression", "entity_type": "Gene_expression", "start": 12, "end": 12}, {"id": "T136", "text": "expression", "entity_type": "Gene_expression", "start": 17, "end": 17}, {"id": "T137", "text": "consequence", "entity_type": "Positive_regulation", "start": 28, "end": 28}]}
